6,9-DIFLUORO-11-HYDROXY-16-METHYL-3-OXO-17-(1-OXOPROPOXY)ANDROSTA-1,4-DIENE-17-CARBOTHIOIC ACID, (6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-
UNII YXC5X4NLK5

Substance Identification & Data

This profile provides standardized clinical and technical data for 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YXC5X4NLK5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 80474-45-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YXC5X4NLK5

CAS Registry Number

80474-45-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

6,9-DIFLUORO-11-HYDROXY-16-METHYL-3-OXO-17-(1-OXOPROPOXY)ANDROSTA-1,4-DIENE-17-CARBOTHIOIC ACID, (6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H30F2O5S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QGESYFOFLPJDJW-CQRCZTONSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

10053741

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C=1C(C=C2[C@](C1)([C@@]3([C@@](C[C@@H]2F)([C@]4([C@](C[C@@H]3O)([C@@]([C@@H](C4)C)(OC(CC)=O)C(S)=O)C)[H])[H])F)C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.